|
Biomerieux SA - Comparative Business Analysis Snapshot
Business Description
Biomerieux SA. The Group's principal activity is to provide clinical diagnosis. The Group offers 'in vitro' diagnosis which serves as the basis for medical diagnosis, patient treatment and therapy monitoring. The Group contributes to the field of infectious diseases such as hepatitis, HIV, tuberculosis and respiratory infection and pathologies such as cancer and cardiovascular diseases. The Group performs clinical diagnosis through three technologies, bacteriology, immunoassays and molecular biology. The industrial applications include the analysis of the industrial sample like food, pharmaceutical and cosmetic products. The environment sample of water, air and surface determines the microbiological quality. The Group operates in Europe, North America, Asia-Pacific and Latin America.
Competitor Analysis
This analysis compares Biomerieux SA with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
